MIR4263

Across TCGA pan-cancer cohorts, MIR4263 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MIR4263 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR4263 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR4263 expression acts as an unfavorable survival marker, although some lineages such as BRCA and OV show a favorable association.

BLCA, BRCA, and HNSC are the cancer types where MIR4263 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Quartile	All	0.525	0.710	<.001	116	view →
BRCA	DFS	Tertile	IV	0.791	0.216	.003	44	view →
HNSC	DFS	Median	III,IV	0.243	0.455	.001	40	view →
OV	DFS	Tertile	IV	0.691	0.355	.002	34	view →
UCS	DFS	Tertile	IV	0.885	0.250	.024	24	view →
ESCA	DFS	Tertile	IV	0.704	0.325	.024	15	view →
MESO	OS	Median	All	0.297	0.672	.023	12	view →
UCEC	DFS	Tertile	II,III,IV	0.636	0.794	.028	12	view →
COAD	DFS	Quartile	IV	0.855	0.300	.029	9	view →
READ	DFS	Median	All	0.428	0.745	.015	9	view →
LIHC	OS	Quartile	All	0.581	0.715	.026	7	view →
GBM	OS	Tertile	All	0.310	0.516	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MIR4263–BLCA (DFS)

Open the BLCA breakdown →